课题基金 / 基金详情

Induction of apoptosis in human glioma cells by recombinant human Fas lignd expressed in Baculovirus system

Induction of apoptosis in human glioma cells by recombinant human Fas lignd expressed in Baculovirus system
杆状病毒系统表达的重组人Fas配体诱导人胶质瘤细胞凋亡
批准号:
08671589
负责人:
ABE Masamitsu
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

ABE Masamitsu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Fas/APO-1/CD95 ligand (FasL) is a 40kD type II transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) family and has ability to induce apoptosis in sensitive target cells by binding to its receptor Fas/APO-1/CD95. Aurographa california nuclear polyhedrosis virus (AcMNPV) is the prototype virus of the family Baculoviridae. Baculovirus has polyhedrin promoter, which can express foreign proteins at levels ranging from 1 to 500 mg/liter. To develop an expression system yielding large amount of FasL,we have constructed baculovirus vector containing cDNA of FasL under polyhedrin promoter control. Hence, the expression of recombinant human FasL (rh-FasL) was detected by immunocytochemistry and Western blotting respectively. The rh-FasL showed cytotoxic activity against human glioma cell line T98G in a dose-dependent manner. The induction of apoptosis by the Fas/FasL system could be a new strategy for the treatment of malignant brain tumors, which are resistant for other conventional therapies. The baculovirus exptession system is a powerful tool to produce a large amount of biologically active rh-FasL.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
田渕和雄: "脳腫瘍をめぐる分子生物学的知見." 週刊医学界新聞(脳腫瘍-発生要因から遺伝子治療まで). 5-7 (1997)
Kazuo Tabuchi:“脑肿瘤的分子生物学发现。”周刊 Igaku Kai Shimbun(脑肿瘤 - 从发育因素到基因治疗)5-7(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田渕 和雄: "グリオーマ" 三輪書店, 162 (1997)
田渊一夫:《神经胶质瘤》三轮书店,162 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toda K,et al.: "The cytocidal actiity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas Ligand/Fas system" Jpn J Cancer Res. vol.87. 972-976 (1996)
Toda K 等人:“OK-432 激活的单核细胞对人神经胶质瘤细胞的杀细胞活性部分是通过 Fas 配体/Fas 系统介导的”Jpn J Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
川口 正二郎: "OK-MCs(OK-432-activated mononuclear cells)の抗脳腫瘍効果におけるFas ligand/Fas系の関与." 神経化学. 35. 462-463 (1996)
Shojiro Kawaguchi:“Fas 配体/Fas 系统参与 OK-MC(OK-432 激活的单核细胞)的抗脑肿瘤作用。神经化学”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Experimental Viral Therapy for the Treatment of Malignant Glioma Using Recombinant Herpes Simplex Virus Type 1
    • 批准号:
      06454418
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.9万
    • 财政年份:
      1994
    • 负责人:
      ABE Masamitsu
    • 依托单位:
    IMMUNOTHERAPY OF MALIGNANT BRAIN TUMORS USING OK-432-ACTIVATED MONONUCLEAR CELLS COMBINED WITH HUMAN MONOCLONAL ANTIBODY AGAINST CANCER
    • 批准号:
      04670866
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1992
    • 负责人:
      ABE Masamitsu
    • 依托单位:
    国内基金
    海外基金
    基于WTAP/METTL3-KRT8-FAS轴探讨卵巢子宫内膜样癌预后及化疗敏感性的临床研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      章杰捷
    • 依托单位:
    基于Fas/Fas-L 信号通路探讨肾小管上皮细胞外泌体对椎间 盘退变的影响及补肾活血汤干预机制
    STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
    • 批准号:
      32360836
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      张全伟
    • 依托单位:
    土家药血筒中血筒素抗RA药效及Fas/caspase-8/-3通路介导滑膜细胞凋亡机制研究
    • 批准号:
      2023JJ40490
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      余黄合
    • 依托单位: